DALLAS, Jan. 29, 2018 -- Texas Capital Bancshares, Inc. (NASDAQ:TCBI), the parent company of Texas Capital Bank, and their board of directors declared a cash dividend of $0.40625 per share of the non-cumulative perpetual preferred stock, Series A, which is traded on the NASDAQ under the symbol “TCBIP”. The Series A Preferred Stock dividend is payable on March 15, 2018, to shareholders of record at the close of business on March 1, 2018.
ABOUT TEXAS CAPITAL BANCSHARES, INC.
Texas Capital Bancshares, Inc. (NASDAQ:TCBI), a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank, a commercial bank that delivers highly personalized financial services to businesses and entrepreneurs. Headquartered in Dallas, the bank has full-service locations in Austin, Dallas, Fort Worth, Houston and San Antonio.
INVESTOR CONTACT
Heather Worley, 214.932.6646
[email protected]


Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Amazon Explores AI Content Marketplace With Media Publishers
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



